Biogen Pharmachem Industries Limited
Others - Trading BSE:531752 NSE:NA Bloomberg:PFL@IN Reuters:WLWT.BO Market Lot: 1 Face Value: 1 ISIN Demat: INE703D01023
Company Announcements
Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
22-JAN-24
Board Meeting Outcome for Un-Audited Financial Result Quarter Ended On 31St December 2023 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015.\r\n\r\n
22-JAN-24
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.
16-JAN-24
Notice Of Extra Ordinary General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 \r\n\r\n
10-JAN-24
Rectification Of Outcome Of Board Meeting Held Today 09.01.2024 And Pursuant To Regulation 30 Of SEBI (LODR) Regulations, 2015 For Appointment And Resignation Of Independent Directors Of The Company.
10-JAN-24
Board Meeting Outcome for Outcome Of Board Meeting Held Today 09.01.2024 And Pursuant To Regulation 30 Of SEBI (LODR) Regulations, 2015 For Appointment And Resignation Of Independent Directors Of The Company.\r\n\r\n
09-JAN-24
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
08-JAN-24
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.\r\n\r\n
26-OCT-23
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
05-OCT-23
Closure of Trading Window
30-SEP-23
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30-SEP-23
Shareholder Meeting / Postal Ballot-Outcome of AGM
30-SEP-23